May 13th 2024
While urologists and oncologists agreed on many barriers and facilitators of first-line treatment intensification for metastatic castrate-sensitive prostate cancer, there were also a number of differing beliefs, including whether there is enough clinical support.
Systematic Review of Comparative Effectiveness Data for Oncology Orphan Drugs
This study critically assessed the published clinical and economic evidence supporting oncology orphan drugs marketed in the United States.
Read More
Cost Savings in Inpatient Oncology Through an Integrative Medicine Approach
An approach including yoga, holistic nursing, and a "healing environment" can decrease medication use, resulting in substantial cost savings in care of inpatient oncology patients.
Read More
Offering home fecal immunochemical tests to eligible patients during influenza vaccination clinic increases colorectal cancer screening rates.
Read More
Colorectal Cancer Screening Use Among Insured Primary Care Patients
Colorectal cancer screening use was similar in 2 divergent primary care populations. Colonoscopy was the most frequently used modality; FOBT was used inconsistently.
Read More
Cost-Effectiveness of 21-Gene Assay in Node-Positive, Early-Stage Breast Cancer
A decision-analytic model was used to estimate cost-effectiveness of adopting a 21-gene assay in treatment decisions for women with early-stage N (1-3)/ER HER2-negative breast cancer.
Read More
Characterizing Medical Care by Disease Phase in Metastatic Colorectal Cancer
This study characterized patterns and costs of medical care by disease phase in patients with newly diagnosed mCRC using a large US national commercially insured claims database.
Read More